Drug Shortage Report for PRIORIX
| Report ID | 185638 |
| Drug Identification Number | 02239208 |
| Brand name | PRIORIX |
| Common or Proper name | Combined measles, mumps and rubella vaccine, live, attenuated |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | WATER RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 0.5ML 1000CCID50 1000CCID50 10000CCID50 |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 10s |
| ATC code | J07BD |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-22 |
| Estimated end date | 2023-03-17 |
| Actual end date | 2023-03-15 |
| Shortage status | Resolved |
| Updated date | 2023-03-16 |
| Company comments | Limited supply available for public programs. Supply unavailable for the private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-02-27 | English | Compare |
| v2 | 2023-02-27 | French | Compare |
| v3 | 2023-03-10 | English | Compare |
| v4 | 2023-03-10 | French | Compare |
| v5 | 2023-03-15 | English | Compare |
| v6 | 2023-03-15 | French | Compare |
| v7 | 2023-03-16 | English | Compare |
Showing 1 to 7 of 7